BOLTBolt Biotherapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Bolt Biotherapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BOLTEsta | $7M#8 | — | 0.6x#2 | 0.9x#3 | 0.1%#5 | 47.1%#6 | -469.3%#4 | -264.1%#11 | — | — | -28.8%#2 | — |
| BFRG | $9M#2 | — | 1.2x#10 | 74.9x#8 | — | 7.1%#11 | -5652.4%#7 | -93.0%#7 | -5287.3%#5 | — | -66.6%#5 | — |
| CNSP | $9M#3 | — | 0.5x#1 | — | — | -7.6%#12 | — | -0.1%#4 | — | — | -24.5%#1 | — |
| XCUR | $9M#1 | — | 9.0x#13 | — | -100.0%#8 | 49.0%#5 | — | -506.2%#13 | — | — | -64.6%#4 | — |
| TRAW | $8M#4 | — | 0.7x#4 | 2.9x#5 | 1134.5%#1 | 105.5%#2 | -640.7%#5 | 79.2%#2 | — | — | -75.7%#8 | — |
| SNGX | $8M#5 | — | 1.2x#9 | 65.8x#7 | -85.8%#7 | -33.7%#13 | -9923.2%#8 | -167.0%#9 | — | 5#1 | -87.0%#10 | — |
| IMNN | $8M#6 | — | — | — | — | — | — | — | — | — | -74.4%#7 | — |
| ACXP | $7M#7 | — | 0.9x#7 | — | — | 43.5%#8 | — | -97.7%#8 | — | — | -66.6%#6 | — |
| SYBX | $7M#9 | — | 0.6x#3 | — | -100.0%#8 | 95.7%#3 | — | -8.4%#5 | — | — | -63.8%#3 | — |
| ENVB | $7M#10 | — | 0.8x#5 | 0.2x#1 | -7.2%#6 | 26.0%#10 | -22.0%#1 | 149.7%#1 | -100.4%#1 | 3#3 | -86.4%#9 | — |
| ERNA | $6M#11 | 0.1x#1 | 2.0x#11 | 11.0x#6 | 755.9%#2 | 68.4%#4 | -1601.2%#6 | -440.1%#12 | -1016.2%#3 | — | — | — |
| PCSA | $5M#12 | 2.9x#2 | — | — | — | 214.5%#1 | — | — | — | — | — | 0.8%#1 |
| PULM | $5M#13 | — | 2.0x#12 | 0.7x#2 | 7.0%#4 | 46.0%#7 | -66.2%#2 | -201.9%#10 | -235.7%#2 | — | — | — |
| XBIO | $5M#14 | — | 0.9x#6 | 1.7x#4 | 19.0%#3 | 32.3%#9 | -95.2%#3 | -44.1%#6 | -1516.8%#4 | 4#2 | — | — |
| LABT | $5M#15 | — | 1.2x#8 | — | — | — | — | 0.0%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice